...
首页> 外文期刊>Journal of Military Veterans Health >Army Malaria Institute – its Evolution and Achievements – Third Decade (1st half): 1985-1990
【24h】

Army Malaria Institute – its Evolution and Achievements – Third Decade (1st half): 1985-1990

机译:陆军疟疾研究所–演变与成就–第三个十年(上半年):1985-1990年

获取原文
   

获取外文期刊封面封底 >>

       

摘要

AbstractThe first half of the third decade (1985-1990) after the establishment of the Malaria Research Unit was characterised by a substantial increase in laboratory and field activities. Various new procedures were developed to discover and counter the increasing problem of parasite resistance to established antimalarial drug regimens. After early findings that the currently-used pyrimethamine/dapsone (Maloprim?) prophylaxis was no longer effective against Plasmodium falciparum malaria, in vitro, ex vivo and pharmacological investigations were undertaken with proguanil and a low dose of dapsone. This led to a field study in Papua New Guinea (PNG) which indicated that such a drug combination might be more effective than Maloprim?. Before the effectiveness of this combination could be determined further, it became obvious that Maloprim?/chloroquine had become? inadequate for the protection of ??ADF soldiers on exercises in PNG. During one of these exercises, the landmark discovery that P. vivax had developed resistance to chloroquine was the first documented evidence that this previously successful standard medication had lost its efficacy against vivax malaria. These findings in 1988/1989 led to the evaluation of mefloquine and doxycycline as alternative prophylactic regimens for ADF personnel serving in malarious areas. In efforts to identify and assess other potential antimalarial drugs, in vitro studies were continued with various strains of P. falciparum. These studies were supplemented by investigations with P. falciparum and P. vivax in non-human primates and by malaria transmission studies with Anopheles farauti mosquitoes. The survey of anopheline mosquitoes in northern Australia indicated the widespread presence of three isomorphic species of An. farauti and the ever-present possibility of re-introducing malaria into northern Australia. Investigations relating to the biological control of mosquitoes were gradually phased out and emphasis was given to the assessment of novel mosquito repellent measures for improved personal protection against malaria.?.
机译:摘要疟疾研究组成立后的第三个十年的前半部分(1985-1990年)的特点是实验室和野外活动大大增加。开发了各种新的程序来发现和应对对既定的抗疟药方案的寄生虫耐药性日益增加的问题。在早期发现目前使用的乙胺嘧啶/氨苯砜(Maloprim?)预防剂对恶性疟原虫的疟疾不再有效之后,进行了异丙酚和低剂量氨苯砜的体外,离体和药理研究。这导致在巴布亚新几内亚(PNG)进行的现场研究表明,这种药物组合可能比Maloprim?更有效。在无法进一步确定这种结合的有效性之前,很明显的是Maloprim?/氯喹已经变成了?不足以保护ADF士兵进行PNG演习。在这些练习之一中,间日疟原虫对氯喹产生抗药性这一具有里程碑意义的发现是第一个有记录的证据,表明这种先前成功的标准药物已经失去了对间日疟疾的功效。 1988/1989年的这些发现导致对甲氟喹和多西环素进行了评估,以作为在疟疾地区服务的ADF人员的替代预防方案。为了确定和评估其他潜在的抗疟药,继续对恶性疟原虫的各种菌株进行了体外研究。通过对非人类灵长类动物中的恶性疟原虫和间日疟原虫进行调查,以及对法氏按蚊进行疟疾传播研究,对这些研究进行了补充。在澳大利亚北部的按蚊蚊子调查显示,An的三个同构物种广泛存在。 farauti和将疟疾重新引入澳大利亚北部的可能性不断。逐步淘汰了与蚊子生物防治有关的研究,并着重于评估新型的驱蚊措施以改善个人对疟疾的防护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号